Nureca Limited Turns Around in Q1 FY27: Posts Profit Before Tax of INR 44.33 Million as Revenues Surge

Nureca Limited has published its unaudited consolidated financial results for the first quarter ended June 30, 2026. The company experienced a strong rebound in top-line growth and pre-tax profitability compared to both the preceding quarter and the corresponding quarter of the previous financial year.

Revenue Performance and Income Growth

During the quarter ended June 30, 2026, Nureca Limited recorded revenue from operations of INR 403.43 million. This marks a notable 13.9% increase compared to INR 354.05 million reported in the preceding quarter ended March 31, 2026, and an 18.0% growth over the INR 341.76 million achieved in the corresponding quarter ended June 30, 2025.

Other income for the quarter stood at INR 18.20 million, down from INR 25.72 million in June 2025 but higher than the INR 10.17 million recorded in March 2026. Consequently, Total Income for Q1 FY27 reached INR 421.63 million, representing a significant sequential improvement from INR 364.22 million in Q4 FY26 and an increase from INR 367.48 million in Q1 FY26.

Expenditure and Operational Costs

Total expenses for the quarter were successfully contained at INR 377.31 million, down from INR 419.33 million in the previous quarter, though slightly higher than INR 355.17 million recorded in June 2025.

Key line items in the expense structure included:

Purchase of Stock-in-Trade: INR 135.24 million, compared to INR 123.80 million in March 2026 and INR 189.29 million in June 2025.

Cost of Material Consumed: INR 49.57 million, up from INR 40.82 million in the year-ago period.

Changes in Inventories: INR 62.09 million.

Employee Benefits Expense: INR 44.29 million, remaining relatively flat compared to INR 44.51 million in June 2025 and INR 41.03 million in March 2026.

Finance Costs: INR 2.01 million, reflecting a reduction from INR 3.00 million in March 2026 and INR 2.48 million in June 2025.

Depreciation and Amortization: INR 6.08 million.

Other Expenses: INR 77.32 million, down from INR 81.08 million in June 2025. Fair value changes and net losses on investments dropped sharply to INR 0.70 million compared to a significant INR 83.37 million in the preceding quarter.

Profitability and Financial Metrics

Driven by higher revenues and lower administrative overheads, Nureca Limited recorded a Profit Before Tax (PBT) of INR 44.33 million for Q1 FY27. This represents a complete turnaround from the PBT loss of INR 55.11 million incurred in Q4 FY26 and a 260% increase over the PBT of INR 12.31 million in Q1 FY26.

After accounting for total tax expenses of INR 13.65 million (comprising current tax of INR 2.40 million and deferred tax of INR 11.25 million), profit from continuing operations stood at INR 30.67 million.

Total Comprehensive Income for the period reached INR 30.51 million, bouncing back strongly from a comprehensive loss of INR 60.17 million in the previous quarter and exceeding the INR 8.13 million reported in the year-ago period.

Capital and Earnings Per Share

As of June 30, 2026, the paid-up equity share capital stood at INR 95.42 million, consisting of equity shares with a face value of INR 10 each. Basic and diluted earnings per share (EPS) for continuing operations for the quarter stood at INR 3.21, reflecting the operational recovery compared to the negative EPS of INR 6.45 recorded in the quarter ended March 31, 2026.

Shares of Nureca Limited was last trading in BSE at Rs. 282.00 as compared to the previous close of Rs. 278.55. The total number of shares traded during the day was 5467 in over 268 trades.

The stock hit an intraday high of Rs. 283.50 and intraday low of 275.50. The net turnover during the day was Rs. 1527453.00.

Source : Equity Bulls

Keywords

Nureca INE0DSF01015 HealthcareSupplies Q1FY27 Q1FY2027 ResultUpdate